In 1993 the US Food and Drug Administration approved Reality a female condom as a contraceptive and a means to prevent transmission of disease. Reality is a lubricated polyurethane sheath that can be inserted as many as 8 hours before intercourse and is secured with an internal and an external ring. In the US the product is marketed over the counter for approximately $9 for a box of 3 and it is targeted to women aged 18-30. While the outer package claims that Reality can help prevent pregnancy and disease transmission the package insert notes that it was only tested in vivo during development for its contraceptive effectiveness. A UN study however found a one-third reduction in mean incidence of sexually transmitted diseases among sex workers in Thailand who were given both male and female condoms versus the incidence among those who only had access to male condoms. Sales of the product grew 207% in 1 year and 76% of first-time users indicated that they would use Reality again. However the package insert reports that the annual pregnancy rate with Reality may be as high as 25% and is 12% with perfect use. If the condom fails to prevent pregnancy it will also fail to prevent disease. Therefore women are advised to continue to rely on the male condom and calls have been made for further testing of the female condom. Currently UN member states can purchase the female condom at greatly discounted prices for AIDS programs and large-scale shipments have been sent to Ghana Indonesia Papua New Guinea Costa Rica Zimbabwe Uganda and the Ivory Coast.